REVIVA PHARMACEUTICALS HOLDINGS, INC. Quarterly Interest Paid, Excluding Capitalized Interest, Operating Activities in USD from Q1 2021 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
Summary
Reviva Pharmaceuticals Holdings, Inc. quarterly/annual Interest Paid, Excluding Capitalized Interest, Operating Activities history and growth rate from Q1 2021 to Q1 2024.
  • Reviva Pharmaceuticals Holdings, Inc. Interest Paid, Excluding Capitalized Interest, Operating Activities for the quarter ending March 31, 2024 was $3.49K.
  • Reviva Pharmaceuticals Holdings, Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2023 was $30.6K.
  • Reviva Pharmaceuticals Holdings, Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2022 was $0.000.
  • Reviva Pharmaceuticals Holdings, Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2021 was $0.000, a 100% decline from 2020.
Interest Paid, Excluding Capitalized Interest, Operating Activities, Quarterly (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $3.49K +$3.49K Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q1 2023 $0 $0 Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q1 2022 $0 $0 Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-16
Q1 2021 $0 Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.